相关实验视频
Updated: Jun 11, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
309
墨西哥成人超重和肥胖管理临床实践指南
Emma A Chávez-Manzanera1,2, Juan M Vera-Zertuche3,4, Martha Kaufer-Horwitz3,5
1Obesity Workgroup, Sociedad Mexicana de Nutrición y Endocrinología, Mexico City, México. emma.chavezm@incmnsz.mx.
Current obesity reports
|October 2, 2024
概括
墨西哥现在有了第一个临床实践指南,用于管理成人超重和肥胖. 这一基于证据的框架为医疗保健专业人员和患者提供了实用,以患者为中心的建议.
科学领域:
- 临床实践指南 临床实践指南
- 肥胖管理 肥胖管理
- 公共卫生 公共卫生
背景情况:
- 在墨西哥,超重和肥胖对健康构成重大风险.
- 需要标准化,基于证据的肥胖管理策略.
研究的目的:
- 制定墨西哥第一个在方法上严格的临床实践指南,用于成人超重和肥胖.
- 提供一个实用,以患者为中心,非耻辱化的管理框架.
主要方法:
- 审查国际临床实践指南.
- 专家共识过程使用GRADE证据决策框架.
- 制定新的建议和良好实践陈述.
主要成果:
- 确定了适合墨西哥的共同建议.
- 制定了20个新的建议和20个良好实践声明.
- 建立了基于证据的肥胖治疗和管理框架.
结论:
- 该指南为墨西哥的医疗保健专业人员提供了一个至关重要的工具.
- 它促进了慢性疾病预防和管理原则.
- 旨在改善超重和肥胖个体的健康结果.
相关概念视频
Obesity
392
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
392
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Gastroesophageal Reflux Disease II: Clinical Features and Management
57
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
57
Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Angina IV: Management
3
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
3

